Cyxone AB Logo

Cyxone AB

CYXO

Overview

Corporate Details

ISIN(s):
SE0007815428 (+2 more)
LEI:
54930034OH16ROAY4K87
Country:
Sweden
Address:
Hyllie Boulevard 34, 215 32 Malmö
Sector:
Health Care
Industry:
Biotechnology

Description

Cyxone AB develops disease-modifying therapies for autoimmune diseases.

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Insider Transactions

Date Insider Name Position Type Shares Value
2023-06-28 Carl Magnus Högerkorp Other Buy 64,950 40,788.60 SEK
2023-06-27 Carl Magnus Högerkorp Other Buy 6,050 3,690.50 SEK
2023-03-03 Carl Magnus Högerkorp Other Buy 100,010 51,005.10 SEK
2023-03-02 Carl Magnus Högerkorp Other Buy 10,873 5,653.96 SEK
2021-07-15 Bert Junno Other Other 1,788,732 7,763,096.88 SEK
2021-07-15 Bert Junno Other Other 1,788,732 N/A
2021-07-14 Bert Junno Other Other 1,788,786 7,790,163.03 SEK
2021-07-14 Bert Junno Other Other 1,788,786 N/A
2021-07-12 Mikeoo Holding AB Other Other 1,788,732 7,441,125.12 SEK
2021-07-12 Mikael Lindstam Other Other 1,788,732 N/A

Peer Companies

Company Country Ticker View
OSE Immunotherapeutics Logo OSE Immunotherapeutics France OSE
Ovoca Bio Plc Logo Ovoca Bio Plc Ireland OVXA
Oxford Biomedica PLC Logo Oxford Biomedica PLC United Kingdom OXB
OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC Logo OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC United Kingdom OCTHF
Oxurion NV Logo Oxurion NV Belgium OXUR
PCI Biotech Holding Logo PCI Biotech Holding Norway PCIB
Pentixapharm Holding AG Logo Pentixapharm Holding AG Germany PTP
Perpetua Medical AB Logo Perpetua Medical AB Sweden PERP
PharmaLundensis AB Logo PharmaLundensis AB Sweden PHAL
Pharma Mar S.A. Logo Pharma Mar S.A. Spain PHM